Back to Search
Start Over
A short-term randomized clinical trial of daily versus alternate day use of travoprost 0.004% in the treatment of ocular hypertension.
- Source :
-
Journal of glaucoma [J Glaucoma] 2013 Feb; Vol. 22 (2), pp. 123-6. - Publication Year :
- 2013
-
Abstract
- Purpose: To compare the daily versus the alternate day use of travoprost 0.004% in lowering the intraocular pressure (IOP) in patients with ocular hypertension.<br />Methods: Fourteen patients with ocular hypertension in both eyes have been randomly assigned to receive travoprost 0.004% once a day in 1 eye and once every other day in the other eye. The main outcome measure was change in the mean of the IOPs measured at 9:00 AM, and 4:00 PM between baseline (before treatment) and measurement of IOPs at 1, 2, 4, 8, and 12 weeks after treatment.<br />Results: After 3 months of treatment, daily use of travoprost 0.004% significantly reduced IOP (mean±standard error of mean) by 6.1±0.5 mmHg (P<0.001) and alternate day use by 5.9±0.3 mmHg (P< 0.001) adjusted from an overall baseline of 24.3±0.5 mm Hg. The difference in the IOP-lowering effect was not statistically significant (P<0.05).<br />Conclusions: Alternate day use of travoprost 0.004% was as safe and effective as its daily use in lowering the IOP in patients with ocular hypertension.
- Subjects :
- Aged
Cloprostenol administration & dosage
Double-Blind Method
Female
Gonioscopy
Humans
Male
Middle Aged
Tonometry, Ocular
Travoprost
Treatment Outcome
Visual Acuity physiology
Antihypertensive Agents administration & dosage
Cloprostenol analogs & derivatives
Intraocular Pressure drug effects
Ocular Hypertension drug therapy
Subjects
Details
- Language :
- English
- ISSN :
- 1536-481X
- Volume :
- 22
- Issue :
- 2
- Database :
- MEDLINE
- Journal :
- Journal of glaucoma
- Publication Type :
- Academic Journal
- Accession number :
- 21946548
- Full Text :
- https://doi.org/10.1097/IJG.0b013e3182311de5